Mereo BioPharma Group PLCNASDAQ:MREO
- LAST PRICE3.4500
- TODAY'S CHANGE (%)-0.1400 (-3.8997%)
- Bid / Lots3.3600/ 21
- Ask / Lots3.4700/ 24
- Open / Previous Close3.6100 / 3.5900
- Day Range
- 52 Week Range
- Volume569,661
Search Criteria
Filter search criteria using below inputs
Click on magnifying glass icon to search
| Company | Country | Symbol |
|---|
- TSX Comp
- TSX Venture
- DJIA
- S&P 500
- NASDAQ
| Time | Volume | MREO |
|---|---|---|
| 09:32 ET | 11870 | 3.6255 |
| 09:34 ET | 3248 | 3.63 |
| 09:36 ET | 4800 | 3.635 |
| 09:38 ET | 1825 | 3.635 |
| 09:39 ET | 1397 | 3.63 |
| 09:41 ET | 2710 | 3.65 |
| 09:43 ET | 1200 | 3.64 |
| 09:45 ET | 7437 | 3.575 |
| 09:48 ET | 3669 | 3.575 |
| 09:50 ET | 3848 | 3.56 |
| 09:52 ET | 10227 | 3.535 |
| 09:54 ET | 5638 | 3.51 |
| 09:56 ET | 3950 | 3.48 |
| 09:57 ET | 3771 | 3.52 |
| 09:59 ET | 722 | 3.535 |
| 10:01 ET | 5556 | 3.57 |
| 10:03 ET | 6867 | 3.55 |
| 10:06 ET | 4157 | 3.555 |
| 10:08 ET | 2741 | 3.56 |
| 10:10 ET | 400 | 3.565 |
| 10:12 ET | 4450 | 3.58 |
| 10:14 ET | 500 | 3.565 |
| 10:15 ET | 300 | 3.565 |
| 10:17 ET | 928 | 3.565 |
| 10:19 ET | 300 | 3.565 |
| 10:21 ET | 2034 | 3.58 |
| 10:24 ET | 1400 | 3.58 |
| 10:26 ET | 1400 | 3.575 |
| 10:28 ET | 486 | 3.56 |
| 10:30 ET | 400 | 3.56 |
| 10:32 ET | 300 | 3.555 |
| 10:33 ET | 300 | 3.55 |
| 10:35 ET | 6895 | 3.535 |
| 10:37 ET | 400 | 3.535 |
| 10:39 ET | 300 | 3.535 |
| 10:42 ET | 2718 | 3.535 |
| 10:44 ET | 1700 | 3.5393 |
| 10:46 ET | 300 | 3.53 |
| 10:48 ET | 6300 | 3.525 |
| 10:50 ET | 4371 | 3.54 |
| 10:51 ET | 6760 | 3.545 |
| 10:53 ET | 10849 | 3.605 |
| 10:55 ET | 2600 | 3.6099 |
| 10:57 ET | 8881 | 3.6366 |
| 11:00 ET | 2761 | 3.65 |
| 11:02 ET | 1087 | 3.64 |
| 11:04 ET | 100 | 3.635 |
| 11:06 ET | 2600 | 3.61 |
| 11:09 ET | 300 | 3.615 |
| 11:11 ET | 2795 | 3.59 |
| 11:13 ET | 660 | 3.588 |
| 11:15 ET | 6361 | 3.578 |
| 11:18 ET | 704 | 3.588 |
| 11:20 ET | 4410 | 3.58 |
| 11:22 ET | 100 | 3.58 |
| 11:24 ET | 4296 | 3.57 |
| 11:26 ET | 13693 | 3.552 |
| 11:27 ET | 2985 | 3.55 |
| 11:29 ET | 4708 | 3.515 |
| 11:31 ET | 14006 | 3.515 |
| 11:33 ET | 5259 | 3.49 |
| 11:36 ET | 5201 | 3.495 |
| 11:40 ET | 600 | 3.495 |
| 11:42 ET | 350 | 3.495 |
| 11:44 ET | 560 | 3.495 |
| 11:47 ET | 600 | 3.495 |
| 11:49 ET | 2876 | 3.5 |
| 11:51 ET | 1500 | 3.4964 |
| 11:54 ET | 500 | 3.495 |
| 11:56 ET | 300 | 3.495 |
| 12:00 ET | 4227 | 3.4801 |
| 12:02 ET | 2220 | 3.46 |
| 12:03 ET | 590 | 3.465 |
| 12:05 ET | 100 | 3.465 |
| 12:07 ET | 12386 | 3.4408 |
| 12:09 ET | 1200 | 3.46 |
| 12:12 ET | 9844 | 3.45 |
| 12:14 ET | 300 | 3.445 |
| 12:20 ET | 5497 | 3.45 |
| 12:21 ET | 200 | 3.455 |
| 12:23 ET | 300 | 3.45 |
| 12:25 ET | 1080 | 3.4578 |
| 12:27 ET | 1000 | 3.4599 |
| 12:30 ET | 1296 | 3.475 |
| 12:34 ET | 100 | 3.475 |
| 12:36 ET | 100 | 3.48 |
| 12:38 ET | 500 | 3.475 |
| 12:41 ET | 100 | 3.48 |
| 12:43 ET | 3876 | 3.485 |
| 12:45 ET | 350 | 3.4899 |
| 12:48 ET | 753 | 3.5 |
| 12:50 ET | 214 | 3.5 |
| 12:56 ET | 1701 | 3.49 |
| 12:57 ET | 100 | 3.485 |
| 12:59 ET | 203 | 3.485 |
| 01:01 ET | 800 | 3.48 |
| 01:03 ET | 100 | 3.47 |
| 01:06 ET | 100 | 3.48 |
| 01:10 ET | 100 | 3.475 |
| 01:14 ET | 1100 | 3.4734 |
| 01:15 ET | 400 | 3.475 |
| 01:17 ET | 787 | 3.46 |
| 01:19 ET | 400 | 3.46 |
| 01:21 ET | 150 | 3.465 |
| 01:24 ET | 200 | 3.47 |
| 01:26 ET | 100 | 3.485 |
| 01:35 ET | 300 | 3.47 |
| 01:39 ET | 100 | 3.475 |
| 01:42 ET | 200 | 3.47 |
| 01:44 ET | 800 | 3.45 |
| 01:46 ET | 334 | 3.45 |
| 01:48 ET | 300 | 3.445 |
| 01:50 ET | 431 | 3.45 |
| 01:51 ET | 4600 | 3.45 |
| 01:53 ET | 644 | 3.44 |
| 01:55 ET | 100 | 3.435 |
| 01:57 ET | 2065 | 3.435 |
| 02:00 ET | 650 | 3.44 |
| 02:02 ET | 2338 | 3.445 |
| 02:04 ET | 1948 | 3.43 |
| 02:08 ET | 244 | 3.425 |
| 02:11 ET | 15044 | 3.435 |
| 02:13 ET | 100 | 3.44 |
| 02:18 ET | 3056 | 3.44 |
| 02:24 ET | 1132 | 3.44 |
| 02:26 ET | 100 | 3.445 |
| 02:27 ET | 3677 | 3.45 |
| 02:31 ET | 1960 | 3.45 |
| 02:33 ET | 400 | 3.45 |
| 02:36 ET | 676 | 3.45 |
| 02:38 ET | 532 | 3.445 |
| 02:40 ET | 1629 | 3.445 |
| 02:42 ET | 100 | 3.445 |
| 02:44 ET | 2804 | 3.43 |
| 02:47 ET | 1144 | 3.4475 |
| 02:49 ET | 163 | 3.445 |
| 02:51 ET | 200 | 3.45 |
| 02:54 ET | 822 | 3.435 |
| 02:56 ET | 200 | 3.43 |
| 02:58 ET | 2467 | 3.405 |
| 03:00 ET | 306 | 3.405 |
| 03:02 ET | 1000 | 3.415 |
| 03:03 ET | 5933 | 3.4 |
| 03:05 ET | 284 | 3.4 |
| 03:07 ET | 2940 | 3.395 |
| 03:09 ET | 1718 | 3.395 |
| 03:12 ET | 3136 | 3.41 |
| 03:14 ET | 2802 | 3.43 |
| 03:16 ET | 1496 | 3.43 |
| 03:18 ET | 2000 | 3.44 |
| 03:20 ET | 1104 | 3.445 |
| 03:21 ET | 300 | 3.45 |
| 03:23 ET | 5413 | 3.45 |
| 03:25 ET | 4072 | 3.425 |
| 03:27 ET | 7301 | 3.43 |
| 03:30 ET | 205 | 3.43 |
| 03:32 ET | 600 | 3.435 |
| 03:34 ET | 10119 | 3.44 |
| 03:36 ET | 8787 | 3.43 |
| 03:38 ET | 2705 | 3.435 |
| 03:39 ET | 3713 | 3.43 |
| 03:41 ET | 1468 | 3.445 |
| 03:43 ET | 1896 | 3.44 |
| 03:45 ET | 32291 | 3.45 |
| 03:48 ET | 8401 | 3.44 |
| 03:50 ET | 1843 | 3.455 |
| 03:52 ET | 12658 | 3.465 |
| 03:54 ET | 1469 | 3.475 |
| 03:56 ET | 11574 | 3.465 |
| 03:57 ET | 4824 | 3.47 |
| 03:59 ET | 4719 | 3.45 |
May 30, 2024
Mereo BioPharma to Participate in Fireside Chat at the Jefferies Global Healthcare Conference, from 7:30AM ET on Thursday May 30, 2024 by Dow Jones
7:30AM ET on Thursday May 30, 2024 by Dow Jones
May 16, 2024
DJ Mereo BioPharma Group Price Target Maintained With a $7.00/Share by Cantor Fitzgerald, from 11:16AM ET on Thursday May 16, 2024 by Dow Jones
11:16AM ET on Thursday May 16, 2024 by Dow JonesDJ Mereo BioPharma Group Price Target Maintained With a $6.00/Share by Needham, from 7:33AM ET on Thursday May 16, 2024 by Dow Jones
7:33AM ET on Thursday May 16, 2024 by Dow Jones
May 15, 2024
Mereo BioPharma Reports First Quarter 2024 Financial Results and Provides Corporate Update, from 4:01PM ET on Wednesday May 15, 2024 by Dow Jones
4:01PM ET on Wednesday May 15, 2024 by Dow JonesPress Release: Mereo BioPharma Reports First Quarter 2024 Financial Results and Provides Corporate Update, from 4:01PM ET on Wednesday May 15, 2024 by Dow Jones
4:01PM ET on Wednesday May 15, 2024 by Dow Jones
| Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
|---|---|---|---|
Mereo BioPharma Group PLC | 483.9M | -13.0x | --- |
Lexicon Pharmaceuticals Inc | 614.5M | -2.1x | --- |
Oric Pharmaceuticals Inc | 606.1M | -5.0x | --- |
Hillevax Inc | 603.6M | -3.7x | --- |
Erasca Inc | 599.7M | -3.0x | --- |
Mind Medicine (MindMed) Inc | 632.5M | -3.0x | --- |
Company Information
Mereo BioPharma Group plc is a biopharmaceutical company. It is focused on the development of therapeutics for rare diseases. It has developed a portfolio of clinical-stage product candidates. The Company has two rare disease product candidates: setrusumab for the treatment of osteogenesis imperfecta (OI) and alvelestat for the treatment of severe alpha-1-antitrypsin deficiency-associated lung disease (AATD-LD) and bronchiolitis obliterans syndrome (BOS). It also has two oncology product candidates in clinical development. It also includes Etigilimab, an antibody against TIGIT (T-cell immunoreceptor with Ig and ITIM domains). Its non-core partnered programme, Navicixizumab, is a bispecific antibody that inhibits delta-like ligand 4 (DLL4) and vascular endothelial growth factor (VEGF). Its non-core programs available for partnership include Acumapimod and Leflutrozole. Acumapimod is a p38 MAP kinase inhibitor therapy for treatment during severe acute exacerbations of COPD (AECOPD).
Contact Information
- Headquarters
- One Cavendish Place, Fourth FloorLONDON, United Kingdom W1G0QF
- Phone
- ---
- Fax
- ---
Executives
- Non-Executive Independent Director
- Michael Wyzga
- Chief Executive Officer, Director
- Denise Scots-Knight
- Chief Financial Officer
- Christine Fox
- Senior Vice President - Clinical Development
- Suba Krishnan
- Senior Vice President - Therapeutic Head
- Jackie Parkin
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $483.9M |
|---|---|
Revenue (TTM) | $9.1M |
Shares Outstanding | 140.3M |
Dividend Yield | 0.00% |
Annual Dividend Rate | --- |
Ex-Dividend Date | 01-01-01 |
Pay Date | 01-01-01 |
Beta | 0.71 |
EPS | $-0.27 |
Book Value | $0.63 |
P/E Ratio | -13.0x |
Price/Sales (TTM) | 53.3 |
Price/Cash Flow (TTM) | --- |
Operating Margin | -444.28% |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.
